Kintara Therapeutics Inc (KTRA)
0.3267
+0.03
(+9.48%)
USD |
NASDAQ |
Jun 26, 16:00
0.336
+0.01
(+2.85%)
After-Hours: 20:00
Kintara Therapeutics Free Cash Flow: -7.262M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -7.262M |
| December 31, 2023 | -6.789M |
| September 30, 2023 | -6.813M |
| June 30, 2023 | -12.10M |
| March 31, 2023 | -15.58M |
| December 31, 2022 | -18.98M |
| September 30, 2022 | -21.92M |
| June 30, 2022 | -20.39M |
| March 31, 2022 | -20.09M |
| December 31, 2021 | -19.50M |
| September 30, 2021 | -19.83M |
| June 30, 2021 | -18.87M |
| March 31, 2021 | -16.76M |
| December 31, 2020 | -13.49M |
| September 30, 2020 | -9.772M |
| June 30, 2020 | -7.928M |
| March 31, 2020 | -7.163M |
| December 31, 2019 | -7.254M |
| September 30, 2019 | -6.508M |
| June 30, 2019 | -6.327M |
| March 31, 2019 | -7.048M |
| December 31, 2018 | -8.408M |
| September 30, 2018 | -9.576M |
| June 30, 2018 | -9.864M |
| March 31, 2018 | -10.78M |
| Date | Value |
|---|---|
| December 31, 2017 | -9.462M |
| September 30, 2017 | -8.779M |
| June 30, 2017 | -8.019M |
| March 31, 2017 | -6.124M |
| December 31, 2016 | -5.573M |
| September 30, 2016 | -5.374M |
| June 30, 2016 | -5.146M |
| March 31, 2016 | -4.401M |
| December 31, 2015 | -4.423M |
| September 30, 2015 | -4.283M |
| June 30, 2015 | -3.853M |
| March 31, 2015 | -3.929M |
| December 31, 2014 | -3.984M |
| September 30, 2014 | -4.002M |
| March 31, 2014 | -4.280M |
| December 31, 2013 | -5.520M |
| September 30, 2013 | -4.488M |
| June 30, 2013 | -3.380M |
| March 31, 2013 | -2.131M |
| December 31, 2012 | -0.0099M |
| September 30, 2012 | -0.0167M |
| June 30, 2012 | -0.0114M |
| March 31, 2012 | -0.0222M |
| December 31, 2011 | -0.0229M |
| September 30, 2011 | -0.0291M |
Free Cash Flow Range, Past 5 Years
-21.92M
Minimum
Sep 2022
-6.327M
Maximum
Jun 2019
-13.17M
Average
-12.79M
Median
Free Cash Flow Benchmarks
| ARCA biopharma Inc | -4.947M |
| Vanda Pharmaceuticals Inc | -11.77M |
| Asensus Surgical Inc | -60.39M |
| Catalent Inc | -123.00M |
| CEL-SCI Corp | -20.40M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.30M |
| Cash from Financing (Quarterly) | 7.993M |
| Free Cash Flow Per Share (Quarterly) | -0.0516 |
| Free Cash Flow Yield | -170.0% |